Drugs / Black Pepper
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04528212 Background | Nov 2020 → Nov 2021 | type 2 diabetes mellitus | Rehab Werida | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Black Pepper | “Glimepiride (4 mg) plus Curcumin (1100 mg) With 5mg Black Pepper per Day” NCT04528212 ↗ |